Voxello’s mission is to bring solutions to market to address the needs of individuals who are currently unable to independently summon help and effectively communicate with caregivers. Patients who face barriers to communication are at a heightened risk of experiencing preventable adverse events. Voxello developed the noddle smart switch to detect the smallest intentional gesture and provide the user the means to control multiple devices with that gesture. Voxello’s noddle-chat speech generating app makes it possible for patents who are unable to speak to effectively communicate with caregivers and be active participants in their care. The noddle has been cleared to market by the FDA and is already in use in over 12 medical centers across the US. In 2019, Voxello will release a gesture learning sensor for the noddle and a bilingual version of noddle-chat to address the needs of patients with limited English proficiency.
Company HQ State:
Company HQ Country:
2013 (Incorporated in 2014)
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):